Pages that link to "Q59187364"
Jump to navigation
Jump to search
The following pages link to Man-Fung Yuen (Q59187364):
Displaying 50 items.
- Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region (Q26750444) (← links)
- Nucleoside/nucleotide analogues in the treatment of chronic hepatitis B (Q27030828) (← links)
- Risk Factors and Post-Resection Independent Predictive Score for the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma (Q28550305) (← links)
- A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B (Q28741501) (← links)
- Sequence variations of full-length hepatitis B virus genomes in Chinese patients with HBsAg-negative hepatitis B infection. (Q33717096) (← links)
- Artificial neural network accurately predicts hepatitis B surface antigen seroclearance. (Q33734215) (← links)
- Genome-wide association study of hepatocellular carcinoma in Southern Chinese patients with chronic hepatitis B virus infection. (Q34103390) (← links)
- No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. (Q34308762) (← links)
- High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. (Q34391308) (← links)
- Association of hepatitis B virus pre-S deletions with the development of hepatocellular carcinoma in chronic hepatitis B. (Q34772665) (← links)
- Role of HLA-DP polymorphisms on chronicity and disease activity of hepatitis B infection in Southern Chinese (Q34794443) (← links)
- Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome. (Q34981453) (← links)
- Mutational analysis for Wilson's disease. (Q34998929) (← links)
- New susceptibility and resistance HLA-DP alleles to HBV-related diseases identified by a trans-ethnic association study in Asia (Q35092586) (← links)
- Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety (Q35535861) (← links)
- Evolutionary Changes of Hepatitis B Virus Pre-S Mutations Prior to Development of Hepatocellular Carcinoma (Q35793292) (← links)
- Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure. (Q36341736) (← links)
- Estradiol induces apoptosis via activation of miRNA-23a and p53: implication for gender difference in liver cancer development. (Q36544261) (← links)
- Evidence of serologic activity in chronic hepatitis B after surface antigen (HBsAg) seroclearance documented by conventional HBsAg assay (Q37135543) (← links)
- Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. (Q37408920) (← links)
- Defining normal liver stiffness range in a normal healthy Chinese population without liver disease (Q37415362) (← links)
- Longitudinal study of hepatitis activity and viral replication before and after HBeAg seroconversion in chronic hepatitis B patients infected with genotypes B and C. (Q37597596) (← links)
- Future prevention and treatment of chronic hepatitis B infection. (Q38036837) (← links)
- Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment. (Q38174178) (← links)
- Hepatitis B reactivation in occult viral carriers undergoing hematopoietic stem cell transplantation: A prospective study. (Q38383062) (← links)
- Oral nucleos(t)ide Analogs Alone After Liver Transplantation in Chronic Hepatitis B with Preexisting rt204 Mutation (Q38668028) (← links)
- Prevention and management of hepatitis B virus reactivation in cancer patients (Q38688782) (← links)
- DNA polymerase inhibitors for treating hepatitis B: a safety evaluation. (Q38692333) (← links)
- Hepatitis B: treatment choice and monitoring for response and resistance. (Q38707903) (← links)
- Chronic Hepatitis B Virus Infection: Disease Revisit and Management Recommendations (Q38721546) (← links)
- Emerging drugs for the treatment of hepatitis B. (Q38759805) (← links)
- The use of transient elastography in the management of chronic hepatitis B. (Q39099395) (← links)
- Real-life efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir in chronic hepatitis C patients in Hong Kong (Q39169232) (← links)
- Clinicopathological and prognostic significance of serum and tissue Dickkopf-1 levels in human hepatocellular carcinoma. (Q39466501) (← links)
- Interleukin-1β increases the risk of gastric cancer through induction of aberrant DNA methylation in a mouse model (Q39654266) (← links)
- Inverse relationship between hepatic steatosis and hepatitis B viremia: Results of a large case-control study. (Q40096029) (← links)
- Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome. (Q40203260) (← links)
- Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years. (Q40261285) (← links)
- Deep sequencing analysis of quasispecies in the HBV pre-S region and its association with hepatocellular carcinoma. (Q40269219) (← links)
- Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy (Q40341578) (← links)
- The role of interleukin-27 in predicting spontaneous HBeAg seroconversion in chronic hepatitis B infection (Q40362295) (← links)
- Hepatitis B virus core-related antigen as a surrogate marker for covalently closed circular DNA. (Q40404314) (← links)
- Reduction of covalently closed circular DNA with long-term nucleos(t)ide analogue treatment in chronic hepatitis B. (Q40509636) (← links)
- Association of Hepatitis B Core-Related Antigen With Hepatitis B Virus Reactivation in Occult Viral Carriers Undergoing High-Risk Immunosuppressive Therapy. (Q40575142) (← links)
- Hepatitis B virus full-length genomic mutations and quasispecies in hepatocellular carcinoma (Q40893329) (← links)
- Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone (Q41099012) (← links)
- Longitudinal profiles of highly sensitive hepatitis B surface antigen levels: re-evaluation of HBsAg seroclearance. (Q41209771) (← links)
- Hepatitis B surface antigen seroclearance during nucleoside analogue therapy: surface antigen kinetics, outcomes, and durability. (Q41249783) (← links)
- Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts liver cancer development in chronic hepatitis B patients under antiviral treatment (Q41471144) (← links)
- Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: results from a multicentre study. (Q41633369) (← links)